Attention Deficit/Hyperactivity Disorder among Adults in the United States David Alexander SclarLinda M. RobisonAmbartsum M. Oganov Short Communication 23 August 2012 Pages: 97 - 101
Extracting Knowledge from Failed Development Programmes Yaning Wang Leading Article 23 August 2012 Pages: 91 - 96
Stem Cell-Based Toxicity Screening Sebastian GreenhoughDavid C. Hay Leading Article 23 August 2012 Pages: 85 - 89
Portfolio Decisions in Early Development Michael Herschel Current Opinion 23 August 2012 Pages: 77 - 84
Phase III ATENA Trial of Exemestane Discontinued Mel Sweetlove Trial Report 23 August 2012 Pages: 45 - 47
Drugs in Clinical Development for Type 2 Diabetes Mellitus Adis Profile Summary 23 August 2012 Pages: 27 - 43
Methodological Issues in the Design of Paediatric Pharmacokinetic Studies Gilbert J. BurckartKristina E. EstesPravin R. Jadhav Review Article 23 August 2012 Pages: 13 - 22
Comparative Effectiveness Research in the Regulatory Setting Jay P. SiegelNorman RosenthalSusan Odenthal Current Opinion 23 August 2012 Pages: 5 - 11
The Pharmaceutical Medicine Year that Was, 2011 Anthony W. Fox Commentary 23 August 2012 Pages: 1 - 3
Drugs in Clinical Development for Prostate Cancer Adis Profile Summary 23 August 2012 Pages: 387 - 404
The Impact of Nonadherence to Inhaled Long-Acting β2-Adrenoceptor Agonist/Corticosteroid Combination Therapy on Healthcare Costs in Difficult-to-Control Asthma Ciaran O’NeillJacqui GambleLiam G. Heaney Short Communication 23 August 2012 Pages: 379 - 385
How the Biopharmaceutical Industry Can Navigate a Healthcare Ecosystem Increasingly Driven by Demands for Comparative Effectiveness Research John J. DoyleNathalie Horowicz-Mehler Current Opinion 23 August 2012 Pages: 361 - 365
Does Package Design Matter for Patients? Thomas WilkeSabrina MüllerTobias Loder Original Research Article 23 August 2012 Pages: 307 - 317
Advances in Gene Delivery Systems Kenya KamimuraTakeshi SudaDexi Liu Review Article 23 August 2012 Pages: 293 - 306
Drugs in Clinical Development for Chronic Obstructive Pulmonary Disease Adis Profile Summary 23 August 2012 Pages: 251 - 258
63rd Annual Meeting of the American Academy of Neurology Sue Pochon Meeting Report 23 August 2012 Pages: 245 - 250
Overview of Guidelines and Recommendations for the Planning, Conduct and Reporting of Company-Sponsored Observational, Noninterventional Studies in Europe Gabriel SchnetzlerColin Hayward Review Article 23 August 2012 Pages: 235 - 244
Clinical Data Collection, Cleaning and Verification in Anticipation of Database Lock Vera PomerantsevaOlga Ilicheva Review Article 23 August 2012 Pages: 223 - 233
Achieving Ethnic Diversity in Trial Recruitment Jing Jing LiuEmma DavidsonAziz Sheikh Current Opinion 23 August 2012 Pages: 215 - 222
Drug and Device Shortages Hiroto NarimatsuTomoko MatsumuraMasahiro Kami Correspondence 23 August 2012 Pages: 167 - 167
23rd Annual EuroMeeting of the Drug Information Association Mary Ellen Kitler Meeting Report 23 August 2012 Pages: 161 - 166
The Role of Health-Related Quality of Life Data in the Drug Approval Processes in the US and Europe Patrick MarquisMartine CaronCatherine Acquadro Original Research Article 23 August 2012 Pages: 147 - 160
Standardizing the Benefit-Risk Assessment of New Medicines Lawrence LibertiJames Neil McAuslaneStuart Walker Current Opinion 23 August 2012 Pages: 139 - 146
Latin American Physicians’ Attitudes Toward Participation in Clinical Trials Harold E. GlassJesse M. Glass Original Research Article 23 August 2012 Pages: 87 - 94
Maintaining and Enhancing the Value of Spontaneous Reporting Programmes Kathlyn J. Ronaldson Current Opinion 23 August 2012 Pages: 83 - 86
